Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Radiology
Volume 2016, Article ID 2670495, 6 pages
http://dx.doi.org/10.1155/2016/2670495
Case Report

Multisystem Radiologic Manifestations of Erdheim-Chester Disease

Department of Radiology, Stony Brook University Hospital, 101 Nicolls Road, Stony Brook, NY 11794, USA

Received 1 November 2015; Revised 3 April 2016; Accepted 12 April 2016

Academic Editor: Turab Chakera

Copyright © 2016 Umairullah Lodhi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Chester, “Über Lipoidgranulomatose,” Virchows Archiv für Pathologische Anatomie und Physiologie und für Klinische Medizin, vol. 279, no. 2, pp. 561–602, 1930. View at Publisher · View at Google Scholar · View at Scopus
  2. E. L. Diamond, L. Dagna, D. M. Hyman et al., “Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease,” Blood, vol. 124, no. 4, pp. 483–492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. H. L. Jaffe, Metabolic, Degenerative and Inflammatory Diseases of Bones and Joints, Urban and Schwarzenberg, Munich, Germany, 1970.
  4. R. Carpinteri, I. Patelli, F. F. Casanueva, and A. Giustina, “Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 23, no. 5, pp. 639–650, 2009. View at Publisher · View at Google Scholar
  5. E. R. Volpicelli, L. Doyle, J. P. Annes et al., “Erdheim-Chester disease presenting with cutaneous involvement: a case report and literature review,” Journal of Cutaneous Pathology, vol. 38, no. 3, pp. 280–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Veyssier-Belot, P. Cacoub, D. Caparros-Lefebvre et al., “Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases,” Medicine, vol. 75, no. 3, pp. 157–169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Haroche, Z. Amoura, S. G. Trad et al., “Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: results in eight patients,” Arthritis and Rheumatism, vol. 54, no. 10, pp. 3330–3336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. E. Sanchez, C. Mora, M. Macia, and J. F. Navarro, “Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literature,” International Urology and Nephrology, vol. 42, no. 4, pp. 1107–1112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Arnaud, I. Pierre, C. Beigelman-Aubry et al., “Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature,” Arthritis and Rheumatism, vol. 62, no. 11, pp. 3504–3512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Haroche, L. Arnaud, and Z. Amoura, “Erdheim-Chester disease,” Current Opinion in Rheumatology, vol. 24, no. 1, pp. 53–59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Murray, M. Marshall, E. England, J. Mander, and T. M. H. Chakera, “Erdheim-chester disease,” Clinical Radiology, vol. 56, no. 6, pp. 481–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Drier, J. Haroche, J. Savatovsky et al., “Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings,” Radiology, vol. 255, no. 2, pp. 586–594, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Cavalli, B. Guglielmi, A. Berti, C. Campochiaro, M. G. Sabbadini, and L. Dagna, “The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases,” Annals of the Rheumatic Diseases, vol. 72, no. 10, pp. 1691–1695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Arnaud, B. Hervier, A. Néel et al., “CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients,” Blood, vol. 117, no. 10, pp. 2778–2782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Dion, C. Graef, J. Haroche et al., “Imaging of thoracoabdominal involvement in Erdheim-Chester disease,” American Journal of Roentgenology, vol. 183, no. 5, pp. 1253–1260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Haroche, Z. Amoura, F. Charlotte et al., “Imatinib mesylate for platelet-derived growth factor receptor-beta positive Erdheim-Chester histiocytosis,” Blood, vol. 111, no. 11, pp. 5413–5415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Alharthi, A. Calleja, P. Panse et al., “Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease,” European Journal of Echocardiography, vol. 11, article E25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Haroche, P. Cluzel, D. Toledano et al., “Images in cardiovascular medicine. Cardiac involvement in erdheim-chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients,” Circulation, vol. 119, no. 25, pp. e597–e598, 2009. View at Publisher · View at Google Scholar · View at Scopus